BD - Earth day 2024

Mentice and RAD-AID collaborate to help improve access to interventional radiology in regions of the world with limited resources

Wednesday, March 20, 2019

Mentice AB, a leading global provider of endovascular performance solutions, has entered into an agreement with the non-profit public service RAD-AID to donate high-fidelity simulators to provide training in diagnostic procedures. Interventional radiology (RI) in various regions of the world that have limited resources. Under the terms of the agreement, Mentice is committed to providing software, hardware and experience in simulators to RI educational teams of RAD-AID.

In his comments on the agreement, Mentice general manager Göran Malmberg said: "RAD-AID is doing an incredible job of bringing the benefits of the IR to various underprivileged communities around the world." It is a great honor and privilege. work with RAD-AID to help improve access to and outcomes of patient care in these marginalized communities. "

Launched in 2008, RAD-AID is a non-profit organization under the terms of Article 501c3, which is committed to providing radiology and imaging solutions and technologies to developing countries and communities that lack medical services. "It's easy to forget," adds Malmberg, "that for many people, even X-ray images that are relatively inexpensive are still a luxury." In Mentice, we can make a real contribution, helping to improve access and performance. RI. "

RAD-AID works in more than 30 countries around the world and has more than 10,000 volunteers from 100 countries, 73 university branches and an annual congress on global health radiology. "RAD-AID programs are multidisciplinary and combine innovative technologies, infrastructure planning and educational initiatives, and this multidisciplinary collaboration is fundamental and by working with Mentice, we can help bring effective RI programs to some of the most needy patients in the world." , explained Dr. Daniel Mollura, founder and general manager of RAD-AID International.